WHO ICTRP trial

Clinical Study of Low-Concentration Atropine Eye Drops in Myopia Control

ChiCTR2500113604 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2500113604
Public title Clinical Study of Low-Concentration Atropine Eye Drops in Myopia Control
Scientific title Clinical Study of Low-Concentration Atropine Eye Drops in Myopia Control
Primary sponsor Henan Provincial Eye Hospital
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Interventional study
Countries China
Conditions Myopia;9D00.0
Interventions 0.01% Atropine Group:Use 0.01% atropine eye drops once daily at night.;0.025% Atropine Group:Use 0.025% atropine eye drops once daily at night.;0.05% Atropine Group:Use 0.05% atropine eye drops once daily at night.
Registration date Dec 1, 2025
Target size 0.01% Atropine Group:110;0.025% Atropine Group:110;0.05% Atropine Group:110
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations